XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Assets and Liabilities - Narrative (Details)
3 Months Ended
Jan. 04, 2021
USD ($)
Dec. 31, 2021
USD ($)
Level 3    
Fair Value, Assets and Liabilities    
FDA approval time frame for valuation 30 months  
Level 3 | Measurement input, FDA approval    
Fair Value, Assets and Liabilities    
Contingent value right liability measurement input 0.10  
Level 3 | Measurement input, discount rate    
Fair Value, Assets and Liabilities    
Contingent value right liability measurement input 0.07  
Kleo    
Fair Value, Assets and Liabilities    
Amount received per contingent value right upon regulatory approval $ 1  
Contingent value right term period 30 months  
Maximum amount payable for contingent value rights $ 17,300,000  
Fair value of contingent value right $ 1,457,000  
Recognized gain on contingent value right   $ 1,457,000